A part of the capex is planned for the domestic market while some of it would also go into the U.S. business, the chairperson ...

Investments will target both domestic and US markets, with a split allocation for maintenance and capacity expansion in key ...

Piramal Pharma is investing USD 85 million this fiscal for expansion and maintenance, with USD 30 million already spent in ...

Piramal Pharma, aiming for USD 2 billion revenue by FY30, will invest USD 85 million in capex this fiscal for capacity ...

Revenue from operations rose to Rs 2,242 crore in the second quarter as compared with Rs 1,911 crore in the year-ago period, ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced ...

Piramal Pharma's company's revenue for the quarter under review stood at Rs 2,242 crore as compared to Rs 1,911 crore which ...

A capex of about USD 85 million is being utilized by Mumbai-headquartered company, Piramal Pharma, for various initiatives, ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced its standalone and ...

Piramal Pharma Solutions (PPS), the global contract manufacturing division of Piramal Pharma, has already announced an investment of USD 80 million in expanding its sterile injectables facility in ...

Get the latest Business News, Live Share & Stock Market Updates, Top News from India and across world. Read Top Business News ...